Cardiovascular consequences of immunosuppressive drug treatment: a comparative study of cyclosporine A and cyclosporine G.
Roullet
J B
JB
Division of Nephrology, Hypertension, and Clinical Pharmacology, Oregon Health Sciences University, Portland 97201.
Xue
H
H
Burdman
E A
EA
Chapman
J
J
McCarron
D A
DA
Bennett
W M
WM
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000633:toxicity*; D003524:Cyclosporins / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D007166:Immunosuppressive Agents / Q000633:toxicity*; D066298:In Vitro Techniques; D008274:Magnesium / Q000097:blood; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D014655:Vascular Resistance / Q000187:drug effects*
D001786:Blood Glucose; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D009599:Nitroprusside; C045571:cyclosporin G; D016572:Cyclosporine; D002784:Cholesterol; D008274:Magnesium; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine